Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study

Jean–Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Geboes, Aurélien Lambert, Emmanuel Mitry, Philippe A. Cassier, Jean‐Frédéric Blanc, Lorenzo Pilla, Jaime Feliú, Mercedes Rodríguez Garrote, Roberto Pazo-Cid, Inmaculada Gallego, Karin Enell Smith, Peter Ellmark, Yago Pico de Coaña, Sumeet Ambarkhane, Teresa Macarulla